The new guidelines provide a comprehensive roadmap for improving the testing and modeling of drug permeability by looking at the differences of three areas: On computers (In Silico): Scientists use ...
Dr. Cooper is the academic lead for the project titled SARS-CoV-2 in silico protein modelling and determination of novel therapeutic drug candidates to treat COVID19. Disclaimer: AAAS and EurekAlert!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback